H.R. 639: Improving Regulatory Transparency for New Medical Therapies Act
- Introduced:
Feb 2, 2015
114th Congress, 2015–2017- Status:
-
Enacted — Signed by the President on Nov 25, 2015
This bill was enacted after being signed by the President on November 25, 2015.
- Law:
Pub.L. 114-89
- Sponsor:
-
- Text:
-
Read Text »
Last Updated: Nov 18, 2015
Length: 6 pages
About the bill
Full Title
To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.
History
|
|
|
Earlier Version —
Reported by Committee
This activity took place on a related bill, H.R. 4299 (113th). |
|
|
|
Introduced
This is the first step in the legislative process. |
|
|
|
Reported by Committee
A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
|
|
Passed House
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made. |
|
|
|
Passed Senate with Changes
The Senate passed the bill with changes not in the House version and sent it back to the House to approve the changes. The vote was by Unanimous Consent so no record of individual votes was made. |
|
|
|
House Agreed to Changes
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was without objection so no record of individual votes was made. |
|
|
|
Enacted — Signed by the President
The President signed the bill and it became law.
|
Links & tools
- Primary Source
-
Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.
Click a format for a citation suggestion: